U.S. markets closed

ResMed Inc. (RSMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
29.740.00 (0.00%)
At close: 11:35AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close29.74
Open29.74
BidN/A x N/A
AskN/A x N/A
Day's Range29.74 - 29.74
52 Week Range17.50 - 29.74
Volume50,400
Avg. Volume1,298
Market Cap43.326B
Beta (5Y Monthly)0.30
PE Ratio (TTM)36.72
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.17 (0.56%)
Ex-Dividend DateAug 18, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • RESMED INC
    MASI: Raising target price to $287.00MASIMO CORP has an Investment Rating of HOLD; a target price of $287.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • GlobeNewswire

    ResMed Announces Participation in the Bank of America Global Healthcare Conference

    SAN DIEGO, Sept. 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 15, 2021, beginning at approximately 5:35 p.m. (British Summer Time) via video webcast. More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay

  • GlobeNewswire

    People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERS

    Continued PAP use linked to 39% higher chance of survival over a 3-year periodLYON, France, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Using PAP (positive airway pressure) therapy as directed can significantly increase sleep apnea patients’ chances of living longer, according to a late-breaking abstract presented today at the virtual European Respiratory Society (ERS) International Congress 2021 and supported by ResMed (NYSE: RMD, ASX: RMD). The landmark ALASKA study, “CPAP Termination and All-Cause Mor

  • GlobeNewswire

    ResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference

    SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021, beginning at approximately 1:15 p.m. (Eastern Daylight Time) via video webcast. More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay wi